" /> Autologous Bladder Cell Carcinoma RNAs/CD40L RNA Electroporated Autologous Matured Dendritic Cells - CISMeF





Preferred Label : Autologous Bladder Cell Carcinoma RNAs/CD40L RNA Electroporated Autologous Matured Dendritic Cells;

NCIt synonyms : Autologous DCs Electroporated with Autologous Tumor-derived IVT RNAs/CD40L IVT RNA; Autologous DCs Electroporated with Autologous Tumor-derived RNAs/CD40L RNA; Bladder Cell Carcinoma RNAs/CD40L RNA-transfected Autologous Dendritic Cells;

NCIt definition : A cell-based preparation in which autologous, mature dendritic cells (DCs) are electroporated with in vitro transcribed (IVT) RNAs encoding for a synthetic form of T-cell protein CD40 ligand (CD40L) and IVT RNA encoding for autologous tumor-associated antigens (TAAs) derived from patient-specific bladder cell carcinoma (BCC) cells, with potential immunostimulatory and antineoplastic activities. Upon electroporation into autologous DCs, the RNA is translated and processed. BCC-specific antigenic peptides are subsequently presented via major histocompatibility complex (MHC) Class I molecules on the DCs surface. When AGS-003-BLD is reintroduced to the patient, the MHC-presented peptides interact with and activate CD8-positive T-cells, which elicits a highly specific cytotoxic T-cell (CTL) response against tumor cells expressing the patient-specific BCC TAAs. The signal cascade initiated by expression of the co-stimulatory molecule CD40L results in the secretion of the inflammatory cytokine IL-12, which further stimulates CTLs.;

Molecule name : AGS-003-BLD;

NCI Metathesaurus CUI : CL512599;

Details


You can consult :


Nous contacter.
08/07/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.